New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 19, 2012
16:25 EDTLOW, INTC, TSN, LGND, GSK, DMND, LRNOn The Fly: Closing Wrap
Stocks on Wall Street were higher after the averages all advanced sharply at the open and maintained gains through the trading day. Optimism about hopes for a resolution to the fiscal cliff helped push stocks into positive territory Friday and that positive momentum carried over as the new week began. Positive economic data from the National Association of Realtors also buoyed investor confidence on the day... ECONOMIC EVENTS: In the U.S., the National Association of Realtors said that resales of existing homes climbed 2.1% last month to a seasonally adjusted annual rate of 4.79M units, beating forecasts for sales to have declined 0.2% from the prior month. The housing market index for November, a barometer of homebuilder sentiment, rose to 46, versus expectations for a flat 41 reading... COMPANY NEWS: Lowe's (LOW) reported earnings per share with charges that met expectations and revenue that beat consensus, sending shares higher $1.98, or 6.19%, to $33.96... Intel's (INTC) CEO Paul Otellini announced plans to retire in May and shares leveled off after some early day volatility, ending up 6c, or 0.30%, to $20.25... MAJOR MOVERS: Among the notable gainers was Tyson Foods (TSN), advancing $1.84, or 10.90%, to $18.72 after its quarterly earnings beat consensus and the company raised its regular dividend and declared a special dividend. Also higher were shares of Ligan Pharmaceuticals (LGND), up $2.40, or 14.40%, to $19.07 after the company's partner GlaxoSmithKline (GSK) said the FDA approved a new indication for its supportive care treatment for a condition associated with chronic hepatitis C. Among noteworthy losers was (DMND), down $1.79 or 11.83%, to $13.34 after the stock was downgraded to Underperform from Hold at Jeffries. Also lower were shares of K12 (LRN), down $3.84, or 18.78%, to $16.61 following a downgrade to Market Perform at Wells Fargo prompted by issues at one of its schools in Colorado. The company said in a midday release that it has been working "for some time" with Colorado Virtual Academy to address the performance issues that have arisen there... INDICES: The Dow was up 207.65, or 1.65%, to 12,795.96; the Nasdaq was up 62.94, or 2.21%, to 2,916.07; and the S&P 500 was up 27.01, or 1.99%, to 1,386.89.
News For LOW;INTC;TSN;LGND;GSK;DMND;LRN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
October 10, 2014
07:14 EDTLRNJackson Square reports 14.77% passive stake in K12
Subscribe for More Information
October 9, 2014
13:08 EDTLRNK12 downgraded to Market Perform from Outperform at Barrington
Barrington downgraded K12 to Market Perform citing weak Q1 enrollment and guidance, and lack of near-term catalysts.
07:07 EDTLRNK12 awarded contract to be curriculum provider for Agora Cyber Charter School
Subscribe for More Information
07:06 EDTLRNK12 sees FY15 enrollments down 3.1% to 124,563
Subscribe for More Information
07:05 EDTLRNK12 sees FY15 revenue $925M-$950M, consensus $944.22M
Subscribe for More Information
07:04 EDTLRNK12 sees Q1 revenue $230M-$240M, consensus $235.74M
Sees operating loss of $11M-$16M, compared to an operating loss of $8.5M in the 1Q14. Operating losses in the first quarter relate to the seasonality of SG&A costs at the beginning of every school year, which includes enrollment center and promotional expenses.
07:03 EDTINTCIntel quarter to be in-line or modestly better, says Piper Jaffray
Piper Jaffray expects Intel's quarterly results on October 14 to be in-line to modestly above consensus. The firm's channel checks indicate PC demand trends will remain stable into year-end amid solid corporate demand. Piper reiterates an Overweight rating on Intel with a $37 price target.
07:02 EDTGSKIsis Pharmaceuticals receives $18M milestone payment from GlaxoSmithKline
Subscribe for More Information
October 8, 2014
16:56 EDTINTCGartner says worldwide PC shipments in Q3 declined 0.5%
Subscribe for More Information
11:11 EDTLGNDLigand Q3 pre-announcement unlikely to rally stock, says Cantor
Cantor said its views Ligand's pre-announcement of better than expected Q3 results as no more than "a shuffling of the deck chairs" since the company did not also raise its view for the fiscal year. The firm said it does not expect upward momentum for the stock in the near-term and maintains its Hold rating on the shares.
10:00 EDTINTCOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:34 EDTLGNDLigand maintains FY14 adjusted EPS $1.50-$1.55, consensus $1.55
Subscribe for More Information
08:33 EDTLGNDLigand sees Q4 revenue $22.5M-$24.5M, consensus $23.54M
08:33 EDTLGNDLigand sees Q3 adjusted EPS 33c-37c, consensus 32c
Subscribe for More Information
06:11 EDTGSKNovartis says expects three executive committee members to leave
Novartis (NVS) confirmed that following completion of the transactions with GlaxoSmithKline (GSK) and Eli Lilly and Company (LLY) in the coming months, that the three business leaders of the Novartis divisions at the center of the transaction will leave the Executive Committee of Novartis. The expected changes to the ECN are subject to the closing of the transactions announced on April 22 - Novartis expects the transaction with GSK to be completed in the first half of 2015, and the transaction with Eli Lilly for its Animal Health Business to close in the first quarter of 2015. George Gunn, currently Division Head, Novartis Animal Health, will reach his contractual retirement age in July 2015 and will retire from Novartis. Upon closing of the Animal Health transaction with Lilly he will leave the ECN. Brian McNamara, currently Division Head, Novartis OTC, will transition to GSK as Head of Americas and Europe for the consumer health businesses, reporting to the President of GSK Consumer Healthcare, effective at closing of the transaction. Andrin Oswald, currently Division Head, Novartis Vaccines, will be leaving Novartis to pursue other opportunities following closing of the transaction with GSK.
October 7, 2014
16:33 EDTINTCIntel initiated with a Market Perform at Northland
Subscribe for More Information
13:34 EDTINTCIntel October volatility elevated into Q3 and revenue outlook
Intel October call option implied volatility is at 35, November is at 28, December is at 24; compared to its 26-week average of 22 according to Track Data, suggesting large near term price movement into the expected release of Q3 results after the market close on October 14.
October 6, 2014
09:05 EDTDMNDDiamond Foods builds dedicated innovation center in Oregon
Subscribe for More Information
08:36 EDTINTCSeagate, Intel invest in hybrid storage company Reduxio
Hybrid storage start-up Reduxio Systems announced that it has closed a $15M Series B funding, led by Seagate Technology (STX) and joined by existing investors Jerusalem Venture Partners, Carmel Ventures and Intel Capital (INTC). In conjunction with this investment, Seagate will obtain a seat on the Reduxio Board of Directors, the company stated.
06:23 EDTINTCIntel to push Broadwell into three notebook segments, DigiTimes reports
Intel is looking to push its 14nm Broadwell processors into three major notebook segments, reports DigiTimes. According to sources from the upstream supply chain, Intel is looking to push Brodawell into the entry-level non-touchscreen traditional notebooks, 2-in-1 devices, and 14- to -17-inch performance-level notebooks. Reference Link
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use